A comparison of pediatric tuberculosis care cascades in public- and private-sector facilities in Mymensingh Division, Bangladesh孟加拉国迈门辛专区公立和私立机构中儿科结核病护理连续性比较BMC Health Services ResearchIF32026-08-190OA
Tuberculosis-Preventive Treatment for Household Contacts at Health Facility and Community Settings in PakistanCLINICAL INFECTIOUS DISEASESIF7.32025-03-010PRE
Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-AnalysisCLINICAL INFECTIOUS DISEASESIF7.32024-02-104OAAI
Two Clinical Prediction Tools to Inform Rapid Tuberculosis Treatment Decision-making in ChildrenOPEN FORUM INFECTIOUS DISEASESIF3.82023-05-044OAAI
Scale-up of Rifapentine and Isoniazid for Tuberculosis Prevention Among Household Contacts in 2 Urban Centers: An Effectiveness AssessmentCLINICAL INFECTIOUS DISEASESIF7.32023-04-216PRE
Tuberculosis care models for children and adolescents: a scoping reviewBULLETIN OF THE WORLD HEALTH ORGANIZATIONIF5.72022-12-027OAAI
Improving enrolment for TB preventive treatmentINTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASEIF3.12022-03-012PRE
Triage of Persons With Tuberculosis Symptoms Using Artificial Intelligence-Based Chest Radiograph Interpretation: A Cost-Effectiveness AnalysisOPEN FORUM INFECTIOUS DISEASESIF3.82021-12-1511OAAI
Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysisBMC MEDICINEIF8.32021-12-144OAAI
Provision of Decentralized TB Care Services: A Detect-Treat-Prevent Strategy for Children and Adolescents Affected by TBPATHOGENSIF3.32021-12-0115OAAI
Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort studyLANCET CHILD & ADOLESCENT HEALTHIF15.52021-05-0124PRE
Ringing the alarm bell: Time to scale up drug-resistant tuberculosis preventive treatmentECLINICALMEDICINEIF102021-04-011OAAI
Preventive treatment of drug-resistant TB in a rural settingINTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASEIF3.12021-03-019PRE
Incorporating patient reporting patterns to evaluate spatially targeted TB interventionsANNALS OF EPIDEMIOLOGYIF32021-02-012OAAI
Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden SettingCLINICAL INFECTIOUS DISEASESIF7.32020-12-0713OAAI
High yields from contact investigation of child index TB patientsINTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASEIF3.12020-08-019PRE
Risk Factors for Adverse Events in Household Contacts Prescribed Preventive Treatment for Drug-resistant Tuberculosis ExposureCLINICAL INFECTIOUS DISEASESIF7.32020-04-0810OAAI
Tuberculosis Preventive Therapy for Individuals Exposed to Drug-resistant Tuberculosis: Feasibility and Safety of a Community-based Delivery of Fluoroquinolone-containing Preventive RegimenCLINICAL INFECTIOUS DISEASESIF7.32019-06-1227PREAI
Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant TuberculosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52019-05-015OAAI
Health-related quality of life among pulmonary tuberculosis patients in Pakistan巴基斯坦肺结核患者的健康相关生活质量QUALITY OF LIFE RESEARCHIF2.72018-08-0218PREAI